Mark A Staples

Title: Mark A Staples: Innovator in Immunoassay Technology

Introduction

Mark A Staples is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of immunoassays, particularly in the area of vitamin B12 testing. His innovative approach has led to advancements that improve the accuracy and reliability of these assays.

Latest Patents

Mark A Staples holds a patent for a method involving a B12 enzyme immunoassay and sample pretreatment. This patent describes a process where denaturing agents used to pretreat test samples are neutralized and deactivated by a treatment agent. This agent is a combination of a buffering agent in acid form and an agent that converts sulfhydryl groups of the denaturing agents to a non-active form, such as disulfides or alkylthio groups. The treatment agent effectively serves its purpose without interfering with subsequent steps of the assay procedure. Additionally, the patent outlines a protocol for a vitamin B12 assay that employs a sequential binding method, which helps avoid various problems associated with traditional B12 assays.

Career Highlights

Mark A Staples is associated with Bio-Rad Laboratories, Inc., a company known for its innovative products in the life sciences and clinical diagnostics sectors. His work at Bio-Rad has allowed him to focus on developing advanced immunoassay techniques that enhance testing accuracy.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including John M Pocekay and Clifford R Bartlett. These collaborations have contributed to the development of innovative solutions in the field of immunoassays.

Conclusion

Mark A Staples is a distinguished inventor whose work in immunoassay technology has made a significant impact on the field. His patented methods and collaborative efforts continue to advance the accuracy of vitamin B12 testing.